Skip to main content

Iron Deficiency

2
Pipeline Programs
6
Companies
11
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
7 programs
1
Fer-in-SolPhase 41 trial
Fer-In-SolN/A1 trial
Ferrous SulfateN/A1 trial
Ferrous sulfateN/A1 trial
Immediate ironN/A1 trial
+2 more programs
Active Trials
NCT00760890Completed171Est. Oct 2005
NCT00642863Completed1,614Est. Jun 2014
NCT01156896Completed23Est. Jul 2014
+4 more trials
Enterprise Therapeutics
1 program
1
Mineral-enriched powderPhase 21 trial
Active Trials
NCT05990166Completed150Est. Mar 2026
Alliance Pharmaceuticals
1 program
Fortified riceN/A1 trial
Active Trials
NCT02572128Completed44Est. Dec 2015
Gedeon Richter
Gedeon RichterHungary - Budapest
1 program
Globifer ForteN/A1 trial
Active Trials
NCT03055559Completed60Est. May 2017
Parexel
ParexelMA - Boston
1 program
FerinjectPHASE_31 trial
Active Trials
NCT00810004Completed245Est. Oct 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesFer-in-Sol
ParexelFerinject
Enterprise TherapeuticsMineral-enriched powder
Gedeon RichterGlobifer Forte
Alliance PharmaceuticalsFortified rice
Human BioSciencesImmediate iron
Human BioSciencesFerrous sulfate
Human BioSciencesWater
Human BioSciencesFerrous Sulfate
Human BioScienceselectrolytic iron
Human BioSciencesFer-In-Sol

Clinical Trials (11)

Total enrollment: 3,161 patients across 11 trials

NCT01444261Human BioSciencesFer-in-Sol

Prevention of Iron Deficiency in Breastfed Infants

Start: Dec 2010Est. completion: Apr 2014219 patients
Phase 4Completed
NCT00810004ParexelFerinject

Maintenance Treatment of Iron Deficiency in IBD Patients

Start: Feb 2009Est. completion: Oct 2010245 patients
Phase 3Completed
NCT05990166Enterprise TherapeuticsMineral-enriched powder

Assessing the Effect of a Mineral-enriched Powder on Iron Deficiency in Women of Reproductive Age

Start: Apr 2023Est. completion: Mar 2026150 patients
Phase 2Completed
NCT03055559Gedeon RichterGlobifer Forte

Trial Protocol GlobiFer - Oral Iron Repletion

Start: Jun 2016Est. completion: May 201760 patients
N/ACompleted
NCT02572128Alliance PharmaceuticalsFortified rice

Mineral Absorption From Fortified Rice Produced With Different Fortification Techniques

Start: Jun 2015Est. completion: Dec 201544 patients
N/ACompleted
NCT01754701Human BioSciencesImmediate iron

Acute vs. Delayed Iron: Effect on Red Cell Iron Incorporation in Severe Malaria

Start: Jun 2013Est. completion: May 2015100 patients
N/ACompleted
NCT01156896Human BioSciencesFerrous sulfate

Malaria and the Safety of Iron Supplements and Iron Fortification

Start: Jul 2010Est. completion: Jul 201423 patients
N/ACompleted
NCT02728141Human BioSciencesWater

Healthy Infant Development Project - Sucrose Component

Start: Nov 2009Est. completion: Jun 2014424 patients
N/ACompleted
NCT00642863Human BioSciencesFerrous Sulfate

Brain and Behavior Depending on Timing of Iron Deficiency in Human Infants

Start: Apr 2008Est. completion: Jun 20141,614 patients
N/ACompleted
NCT00841061Human BioScienceselectrolytic iron

Cereals as a Source of Iron for Breastfed Infants

Start: Jul 2003Est. completion: May 2006111 patients
N/ACompleted
NCT00760890Human BioSciencesFer-In-Sol

Iron and the Breast-Fed Infant: Iron Status and Two Regimens of Iron Supplementation

Start: Jun 2001Est. completion: Oct 2005171 patients
N/ACompleted

Related Jobs

Total Rewards Senior Analyst

CSL BehringCSL Behring
APAC, AU, Victoria, Melbourne, CSL Limited Melbourne; Americas, US-PA, King of Prussia, CSL Behring
5d ago

Total Rewards Senior Analyst

CSL SeqirusCSL Seqirus
APAC, AU, Victoria, Melbourne, CSL Limited Melbourne; Americas, US-PA, King of Prussia, CSL Behring
1w ago

Area Sales Manager, Nephrology Nashville, TN

CSL BehringCSL Behring
Remote
3mo ago

Area Sales Manager, Nephrology Nashville, TN

CSL SeqirusCSL Seqirus
Remote
3mo ago

Area Sales Manager, Nephrology Houston

CSL BehringCSL Behring
Remote
4mo ago

Area Sales Manager, Nephrology Houston

CSL SeqirusCSL Seqirus
Remote
4mo ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.